INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Scope & Guideline

Navigating the Future of Respiratory Health

Introduction

Immerse yourself in the scholarly insights of INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN1027-3719
PublisherINT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 1997 to 2024
AbbreviationINT J TUBERC LUNG D / Int. J. Tuberc. Lung Dis.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address68 BOULEVARD SAINT-MICHEL, 75006 PARIS, FRANCE

Aims and Scopes

The INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE focuses on advancing the understanding, diagnosis, treatment, and prevention of tuberculosis (TB) and related lung diseases. The journal aims to publish high-quality research that informs clinical practice and public health policy, especially in low- and middle-income countries where TB burden remains high.
  1. Tuberculosis Epidemiology and Public Health:
    Research on the epidemiology of tuberculosis, including trends, risk factors, and the impact of socio-economic and environmental determinants on TB transmission and outcomes.
  2. Diagnostic Innovations:
    Studies focusing on the development and evaluation of new diagnostic tools and methods for TB detection, including molecular techniques, imaging modalities, and point-of-care tests.
  3. Treatment Strategies and Drug Resistance:
    Clinical trials and observational studies evaluating treatment regimens for drug-susceptible and multidrug-resistant TB, including pharmacokinetics, drug interactions, and therapeutic monitoring.
  4. Comorbidities and TB:
    Research examining the interactions between TB and other diseases, particularly HIV, diabetes, and respiratory conditions, and their implications for treatment and management.
  5. Post-TB Health and Quality of Life:
    Investigations into the long-term health effects following TB treatment, including the burden of post-TB lung disease, quality of life assessments, and rehabilitation strategies.
  6. Public Health Interventions and Policy:
    Studies assessing the effectiveness of public health interventions, screening programs, and policy initiatives aimed at TB prevention and control.
Recent publications in the journal have highlighted several trending and emerging themes that are gaining attention within the field of tuberculosis and lung disease research. These themes reflect the evolving landscape of TB research, especially in the context of global health challenges.
  1. Impact of COVID-19 on TB Care:
    The intersection of TB and COVID-19 has emerged as a significant theme, with research exploring the effects of the pandemic on TB diagnosis, treatment, and healthcare delivery.
  2. Digital Health and Technology in TB Management:
    There is a growing focus on the use of digital technologies and telemedicine for TB management, including adherence monitoring, virtual consultations, and data management systems.
  3. Health Systems Strengthening and TB Services:
    Emerging studies are increasingly addressing the strengthening of health systems to improve TB care delivery, especially in low-resource settings, emphasizing integrated approaches to health services.
  4. Social Determinants of Health and TB:
    Research exploring the social determinants of health, including stigma, economic factors, and healthcare access, is gaining traction as a critical area for understanding TB epidemiology and outcomes.
  5. Innovative Diagnostic Approaches:
    A trend towards innovative diagnostic methods, including the use of artificial intelligence and machine learning in TB detection and management, is becoming prominent.

Declining or Waning

While the journal continues to cover a broad range of topics related to tuberculosis and lung disease, certain themes appear to be declining in prominence based on recent publications. This may reflect shifts in research focus or changes in public health priorities.
  1. Historical Perspectives on TB:
    Research focusing on historical trends and perspectives of tuberculosis, such as epidemiological studies from past decades, appears to be less frequent, indicating a shift towards contemporary issues.
  2. Basic Science Research:
    There seems to be a decline in purely laboratory-based studies related to the basic science of TB pathogens, as the focus shifts towards clinical applications and translational research.
  3. Non-Communicable Diseases and TB:
    While the intersection of TB with non-communicable diseases (NCDs) has been a topic of interest, it appears to be waning, possibly due to a greater emphasis on direct TB-related issues and immediate public health challenges.

Similar Journals

Cyprus Journal of Medical Sciences

Elevating standards in medical research and inquiry.
Publisher: GALENOS PUBL HOUSEISSN: 2149-7893Frequency: 6 issues/year

Welcome to the Cyprus Journal of Medical Sciences, a distinguished publication dedicated to the advancement of medical knowledge and research. Published by GALENOS PUBL HOUSE, this journal endeavors to uphold the highest standards of scientific inquiry in the medical field. With its ISSN 2149-7893 and E-ISSN 2536-507X, the journal serves as an essential resource for researchers, healthcare professionals, and students seeking to stay abreast of innovative findings and clinical practices. Although currently not listed under Open Access, this journal prioritizes rigorous peer review and the dissemination of impactful research aimed at driving improvements in medical science. The journal welcomes submissions that cover diverse areas within the medical realm, contributing to a more profound understanding of healthcare challenges and solutions. Join us in exploring the frontiers of medical sciences and contributing to a healthier future.

Jornal Brasileiro de Pneumologia

Advancing respiratory health through innovative research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Asian Pacific Journal of Tropical Medicine

Connecting researchers to vital tropical health insights.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1995-7645Frequency: 12 issues/year

Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.

Egyptian Journal of Chest Diseases and Tuberculosis

Exploring breakthroughs in chest diseases and tuberculosis management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

Eurasian Journal of Pulmonology

Elevating the discourse on respiratory diseases globally.
Publisher: KARE PUBLISSN: 2148-3620Frequency: 3 issues/year

The Eurasian Journal of Pulmonology is a premier open access journal dedicated to advancing the field of respiratory medicine and thoracic diseases. Published by KARE PUBL since 1999, the journal serves as an invaluable platform for researchers, clinicians, and students, facilitating the dissemination of innovative research findings and clinical practices. With an emphasis on high-quality and peer-reviewed articles, it aims to foster collaboration and knowledge sharing among professionals in the pulmonology community. Although the journal’s precise impact factor is currently not specified, its commitment to openness and accessibility ensures a broad reach and engagement with vital research, making it a critical resource for those in the academic and medical fields. The journal is based in Istanbul, Turkiye, further enriching its contributions to the Eurasian medical landscape and global health discourse.

International Journal of Mycobacteriology

Fostering global collaboration in mycobacterial studies.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-5531Frequency: 4 issues/year

International Journal of Mycobacteriology is a peer-reviewed, open-access journal published by Wolters Kluwer Medknow Publications that specializes in the field of infectious diseases with a particular emphasis on mycobacterial research. Since its inception in 2012, this journal has emerged as a vital resource for researchers, healthcare professionals, and students aimed at advancing understanding and treatment of mycobacterial infections, including tuberculosis. With the journal being indexed in Scopus and holding a Q3 ranking in both Infectious Diseases and Microbiology (medical) for 2023, it reflects a substantial contribution to scholarly discourse in these domains, despite its current ranking positioning. Authors and readers benefit from the open access model, ensuring widespread dissemination of research findings and fostering collaboration across the global health community. Located in Mumbai, India, the journal continues to thrive with a commitment to quality research and innovation, welcoming contributions that further the exploration of mycobacteriology throughout the converged years from 2012 to 2024.

Thoracic Research and Practice

Exploring New Frontiers in Thoracic Research
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

BMC Pulmonary Medicine

Empowering innovation in pulmonary medicine for a healthier tomorrow.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

Acta Facultatis Medicae Naissensis

Innovative Insights for a Healthier Tomorrow
Publisher: UNIV NIS, FAC MEDICINEISSN: 0351-6083Frequency: 4 issues/year

Acta Facultatis Medicae Naissensis is an esteemed open-access journal published by the University of Niš, Faculty of Medicine, situated in Serbia. Since its inception in 2009, this journal has been a vital platform for the dissemination of innovative research findings in the field of Medicine, particularly focusing on miscellaneous areas within the discipline. With an ISSN of 0351-6083 and an E-ISSN of 2217-2521, it operates under a commitment to free accessibility, enhancing visibility for authors and readers alike since 2012. In the 2023 categorization, it holds a respectable Q4 ranking in Medicine (Miscellaneous) and positions itself at the 34th percentile among general medicine publications in Scopus, reflecting its growing academic impact. Researchers, professionals, and students seeking an interactive scholarly exchange in medicine will find Acta Facultatis Medicae Naissensis a rich resource, contributing significantly to the understanding of health sciences and clinical practice through its diverse range of articles.

THORAX

Advancing pulmonary knowledge, one study at a time.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.